The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Tzianabos Arthur since year 2005.
The trader's CIK number is 1586226.
At the time of the last reporting, Tzianabos Arthur was the President & CEO of Homology Medicines, Inc. .
(stock ticker symbol FIXX).
See this page for all insider trading activities at Homology Medicines, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-01||FIXX||Homology Medicines, Inc.||Sale||12,500||17.81||222,624|
|2019-09-03||FIXX||Homology Medicines, Inc.||Sale||12,500||18.75||234,324|
|2019-08-01||FIXX||Homology Medicines, Inc.||Sale||12,500||17.37||217,112|
|2019-07-01||FIXX||Homology Medicines, Inc.||Sale||12,500||18.98||237,300|
|2019-06-03||FIXX||Homology Medicines, Inc.||Sale||12,500||19.86||248,262|
|2016-08-26||BIND||Bind Therapeutics, Inc||Option Ex||15,000||.44||6,600|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tzianabos Arthur (President & CEO of Homology Medicines, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.